These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7131017)

  • 1. Effect of desmopressin on normal and impaired memory.
    Jenkins JS; Mather HM; Coughlan AK
    J Neurol Neurosurg Psychiatry; 1982 Sep; 45(9):830-1. PubMed ID: 7131017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vasopressin on memory following electroconvulsive therapy.
    Lerer B; Zabow T; Egnal N; Belmaker RH
    Biol Psychiatry; 1983 Jul; 18(7):821-4. PubMed ID: 6615939
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of vasopressin on memory in healthy probands and patients with central diabetes insipidus].
    László FA
    Z Gesamte Inn Med; 1983 Aug; 38(15):413-5. PubMed ID: 6636903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and memory: improvement in normal short-term recall and reduction of alcohol-induced amnesia.
    Millar K; Jeffcoate WJ; Walder CP
    Psychol Med; 1987 May; 17(2):335-41. PubMed ID: 3602225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desglycinamide-9-arginine-8-vasopressin (DGAVP, Organon 5667) in patients with dementia.
    Peabody CA; Thiemann S; Pigache R; Miller TP; Berger PA; Yesavage J; Tinklenberg JR
    Neurobiol Aging; 1985; 6(2):95-100. PubMed ID: 3895014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of desglycinamide-arginine-vasopressin (DGAVP) on memory in patients with korsakoff's syndrome.
    Laczi F; Van Ree JM; Balogh L; Szász A; Járdánházy T; Wágner A; Gáspár L; Valkusz Z; Dobranovics I; Szilárd J
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):177-82. PubMed ID: 6637330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin treatment of cognitive dysfunction in progressive dementia.
    Weingartner H; Kaye W; Gold P; Smallberg S; Peterson R; Gillin JC; Ebert M
    Life Sci; 1981 Dec; 29(26):2721-6. PubMed ID: 7035781
    [No Abstract]   [Full Text] [Related]  

  • 8. A controlled trial of vasopressin treatment of childhood learning disorder.
    Eisenberg J; Chazan-Gologorsky S; Hattab J; Belmaker RH
    Biol Psychiatry; 1984 Jul; 19(7):1137-41. PubMed ID: 6477993
    [No Abstract]   [Full Text] [Related]  

  • 9. Desmopressin (DDAVP) in lumbar puncture.
    Hansen PE; Hansen JH
    Br Med J; 1980 May; 280(6223):1146. PubMed ID: 7000237
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis.
    Hilton P; Hertogs K; Stanton SL
    J Neurol Neurosurg Psychiatry; 1983 Sep; 46(9):854-5. PubMed ID: 6619893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of posttrial administration of vasopressin analogue (DDAVP) to influence memory in healthy, young, male volunteers.
    Beckwith BE; Petros TV; Bergloff PJ; Swenson RR; Paulson R
    Peptides; 1995; 16(8):1327-8. PubMed ID: 8745039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vasopressin treatment on learning in Down's syndrome.
    Eisenberg J; Hamburger-Bar R; Belmaker RH
    J Neural Transm; 1984; 60(2):143-7. PubMed ID: 6238133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of diabetes insipidus with synthetic vasopressin derivatives (effect of 1-deamino-8-D-arginine vasopressin and 1-deamino-valine-8-D-arginine vasopressin)].
    Czakó L; László F; Manning M
    Orv Hetil; 1980 Mar; 121(13):773-8. PubMed ID: 7383655
    [No Abstract]   [Full Text] [Related]  

  • 14. DDAVP, a synthetic analogue of vasopressin, in prevention of headache after lumbar puncture and lumbar pneumoencephalography.
    Hansen PE; Hansen JH
    Acta Neurol Scand; 1979 Sep; 60(3):183-8. PubMed ID: 517118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desmopressin and desglycinamide vasopressin in post-traumatic amnesia.
    Jenkins JS; Mather HM; Coughlan AK; Jenkins DG
    Lancet; 1981 Jan; 1(8210):39. PubMed ID: 6109068
    [No Abstract]   [Full Text] [Related]  

  • 16. Paranoid psychosis after DDAVP therapy for Alzheimer's dementia.
    Collins GB; Marzewski DJ; Rollins MB
    Lancet; 1981 Oct; 2(8250):808. PubMed ID: 6116932
    [No Abstract]   [Full Text] [Related]  

  • 17. Desmopressin: a new drug for the treatment of bleeding disorders.
    Haas D; Nace GS
    J Nephrol Nurs; 1985; 2(2):72-3. PubMed ID: 3845983
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
    Kosman ME
    JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin for hemophilia and other coagulation disorders.
    Med Lett Drugs Ther; 1984 Aug; 26(669):82. PubMed ID: 6332266
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment and effects of desmopressin (DDAVP) in patients with central diabetes insipidus (author's transl)].
    Matsui K; Kimura T; Ota K; Iitake K; Yoshinaga K
    Horumon To Rinsho; 1979 Aug; 27(8):891-5. PubMed ID: 487624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.